{"path":".obsidian/plugins/text-extractor/cache/60f6731c46dfd940217aabb4c3da78df.json","text":"Pramipexole, Bromocriptine, ropinirole pergolide S> Dopamine > receptors Selegiline, rasagiline O ) DOPAC & Dopamine _.% 3-OMD TDOPA decarboxylase ;! L-DOPA E 4 Brain L-amino acid transporter Blood-brain barrier o Periph”e'ry 7 ey g—n R e e COMT DOPA decarboxylase ; - e = S v - e l Entacapone, e Carbidopa tolcapone Adverse effects FIGURE 28-5 Pharmacologic strategies for dopaminergic ther- apy of Parkinson’s disease. Drugs and their effects are highlighted (see text). MAO, monoamine oxidase; COMT, catechol-O-methyl- transferase; DOPAC, dihydroxyphenylacetic acid; L-DOPA, levodopa; 3-OMD, 3-O-methyldopa.","libVersion":"0.2.1","langs":"eng"}